198 related articles for article (PubMed ID: 8771673)
1. [The importance of the clinical classification of chronic glomerulonephritis for the prognosis of its progression and of the efficacy of therapy].
Ratner MIa; Serov VV; Stenina IN; Fedorova ND; Shumakov VI
Ter Arkh; 1996; 68(6):10-3. PubMed ID: 8771673
[TBL] [Abstract][Full Text] [Related]
2. [The dependence of the progression of chronic glomerulonephritis on the clinical and morphological types of glomerulonephritis and on the tubulointerstitial changes].
Ratner MIa; Fedorova ND
Urol Nefrol (Mosk); 1998; (2):22-4. PubMed ID: 9577698
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors of chronic glomerulonephritis and chronic non-inflammatory glomerulopathies rapid progression].
Ratner MIa; Serov VV; Varshavskiĭ VA; Fedorova ND
Ter Arkh; 1998; 70(6):7-11. PubMed ID: 9695214
[TBL] [Abstract][Full Text] [Related]
4. [Histomorphological tubulointerstitial changes in progression of chronic glomerulonephritis].
Ratner MIa; Fedorova ND
Urologiia; 2000; (1):28-30. PubMed ID: 16856458
[TBL] [Abstract][Full Text] [Related]
5. [Prediction of accelerated progression of chronic glomerulonephritis basing on clinical and histomorphological data].
Ratner MIa; Stenina II; Fedorova ND
Ter Arkh; 1999; 71(6):27-30. PubMed ID: 10420451
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of the morphological type of chronic glomerulonephritis and of the tubulointerstitial changes depending on the clinical type of the disease].
Ratner MIa; Fedorova ND
Ter Arkh; 1997; 69(6):10-3. PubMed ID: 9297263
[TBL] [Abstract][Full Text] [Related]
7. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
Ratner MIa; Fedorova ND
Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
[TBL] [Abstract][Full Text] [Related]
8. [Implication of clinical and morphological types of chronic glomerulonephritis, tubulointerstitial changes in prognosis of disease progression].
Ratner MIa; Stenina II; Fedorova ND
Klin Med (Mosk); 1999; 77(1):30-3. PubMed ID: 10097503
[TBL] [Abstract][Full Text] [Related]
9. [Morpho-clinical variants of chronic glomerulonephritis and their significance for the evaluation of the severity of the disease].
Ratner MIa; Gel'fand IM; Varshavskiĭ VA; Rozenfel'd BI; Brodskiĭ MA
Arkh Patol; 1984; 46(11):46-52. PubMed ID: 6525063
[TBL] [Abstract][Full Text] [Related]
10. [Comparative evaluation of the clinical course and dynamics of the morphological changes in chronic glomerulonephritis].
Tov NL; Valentik MF; Vlazneva VA; Kagalovskaia IM; Nesina IA
Ter Arkh; 1986; 58(8):10-3. PubMed ID: 3764748
[TBL] [Abstract][Full Text] [Related]
11. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
[TBL] [Abstract][Full Text] [Related]
12. [The role of tubular interstitial changes in the genesis of the rapid progression of chronic glomerulonephritis].
Ratner MIa; Serov VV; Shumakov VI
Urol Nefrol (Mosk); 1995; (3):7-9. PubMed ID: 7618227
[TBL] [Abstract][Full Text] [Related]
13. [The tubulointerstitial changes in different clinical and morphological types of chronic glomerulonephritis].
Ratner MIa; Fedorova ND; Makurov AI
Urol Nefrol (Mosk); 1997; (2):16-9. PubMed ID: 9206875
[TBL] [Abstract][Full Text] [Related]
14. [The importance of a new classification of chronic glomerulonephritis for determining the prognosis of the disease].
Ratner MIa; Serov VV; Fedorova ND; Stenina II
Arkh Patol; 1998; 60(6):30-2. PubMed ID: 9949902
[TBL] [Abstract][Full Text] [Related]
15. [The progression rates of different morphological forms of chronic glomerulonephritis in the pre-azotemia period (is the morphological form of chronic glomerulonephritis the factor that determines the prognosis?)].
Riabov SI; Dobronravov VA
Ter Arkh; 1994; 66(6):15-8. PubMed ID: 7940356
[TBL] [Abstract][Full Text] [Related]
16. [Recommendations for a clinical classification of chronic glomerulonephritis].
Ratner M; Serov VV; Warschavski WA; Rosenfeld B; Subkin ML; Novikov ID; Sinn W; Klinkmann H
Z Urol Nephrol; 1987 May; 80(5):271-9. PubMed ID: 3617956
[TBL] [Abstract][Full Text] [Related]
17. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
18. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
[TBL] [Abstract][Full Text] [Related]
19. [The course of chronic glomerulonephritis in chronic opisthorchiasis].
Beloborodova EI; Zibnitskaia LI; Kaliuzhina EV
Ter Arkh; 2005; 77(11):44-9. PubMed ID: 16404862
[TBL] [Abstract][Full Text] [Related]
20. [I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis].
Kaliev RR; Budaĭchiev AB; Aldashev AA; Mirrakhimov MM
Ter Arkh; 2005; 77(6):12-5. PubMed ID: 16078593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
